Direct oral anticoagulants are not approved for use in patients with mechanical valves. When used to replace vitamin K antagonists, they may cause catastrophic consequences. The authors describe the case of a patient who, after discontinuation of warfarin and introduction of rivaroxaban, developed thrombosis of his mechanical mitral prosthesis.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000501361DOI Listing

Publication Analysis

Top Keywords

mechanical prosthetic
4
prosthetic heart
4
heart valve
4
valve thrombosis
4
thrombosis patient
4
patient receiving
4
receiving rivaroxaban
4
rivaroxaban direct
4
direct oral
4
oral anticoagulants
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!